We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+10.51%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$104M
AUM Growth
+$8.55M
(+9%)
Cap. Flow
+$7.51M
Cap. Flow
% of AUM
7.22%
Top 10 Holdings %
Top 10 Hldgs %
35.65%
Holding
124
New
22
Increased
30
Reduced
40
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TEAR
TearLab Corporation
TEAR
|
+$1.85M |
| 2 |
FLXN
Flexion Therapeutics, Inc.
FLXN
|
+$1.31M |
| 3 |
Target
TGT
|
+$1.13M |
| 4 |
Ring Energy
REI
|
+$1.03M |
| 5 |
Tactile Systems Technology
TCMD
|
+$979K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Axogen
AXGN
|
+$1.07M |
| 2 |
ENTL
Entellus Medical, Inc. Common Stock
ENTL
|
+$1.05M |
| 3 |
ZAGG
ZAGG Inc Common Stock (Delaware)
ZAGG
|
+$1.05M |
| 4 |
Cencora
COR
|
+$976K |
| 5 |
CryoPort
CYRX
|
+$602K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 59.08% |
| 2 | Technology | 10.55% |
| 3 | Industrials | 9.42% |
| 4 | Financials | 4.89% |
| 5 | Consumer Staples | 3.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INWK
51
DELISTED
InnerWorkings, Inc.
INWK
| $672K | 0.65% |
67,000
-5,000
| -7% | -$53.7K |
|
|
ATHX
52
DELISTED
Athersys, Inc. Common Stock
ATHX
| $658K | 0.63% |
14,535
+2,186
| +18% | +$106K |
|
|
HDP
53
DELISTED
Hortonworks, Inc.
HDP
| $654K | 0.63% |
32,525
| – | – |
|
54
Plus Therapeutics
PSTV
$25.7M
| $644K | 0.62% |
11
+6
| +120% | +$420K |
|
55
General Mills
GIS
$20.2B
| $626K | 0.6% |
+10,556
| New | +$571K |
|
|
FOCL
56
EDAP TMS S.A.
FOCL
$225M
| $614K | 0.59% |
213,800
-7,500
| -3% | -$22.4K |
|
57
3M
MMM
$93.7B
| $606K | 0.58% |
3,081
| – | – |
|
|
TEAR
58
DELISTED
TearLab Corporation
TEAR
| $598K | 0.58% |
1,553,383
+1,343,410
| +640% | +$1.85M |
|
|
OIG
59
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
| $584K | 0.56% |
+5,311
| New | +$622K |
|
60
Verizon
VZ
$202B
| $573K | 0.55% |
10,825
-92
| -0.8% | -$4.52K |
|
61
Riot Platforms
RIOT
$7.95B
| $568K | 0.55% |
+20,012
| New | +$281K |
|
62
Kimberly-Clark
KMB
$37.8B
| $537K | 0.52% |
4,450
| – | – |
|
|
SHPG
63
DELISTED
Shire pic
SHPG
| $516K | 0.5% |
+3,325
| New | +$493K |
|
|
ATRS
64
DELISTED
Antares Pharma, Inc.
ATRS
| $501K | 0.48% |
252,000
-114,000
| -31% | -$248K |
|
|
ASRT
65
DELISTED
Assertio
ASRT
| $488K | 0.47% |
1,011
-185
| -15% | -$71.9K |
|
66
IZEA Worldwide
IZEA
$59.7M
| $486K | 0.47% |
26,899
-19,029
| -41% | -$324K |
|
|
CY
67
DELISTED
Cypress Semiconductor
CY
| $451K | 0.43% |
29,625
+1,000
| +3% | +$15.9K |
|
|
BEAT
68
DELISTED
BioTelemetry, Inc.
BEAT
| $449K | 0.43% |
15,000
| – | – |
|
|
TBCH
69
Turtle Beach Corp
TBCH
$259M
| $438K | 0.42% |
241,575
+84,985
| +54% | +$209K |
|
|
ATTU
70
DELISTED
Attunity Ltd
ATTU
| $419K | 0.4% |
+60,000
| New | +$432K |
|
71
US Bancorp
USB
$99.5B
| $411K | 0.4% |
7,662
| – | – |
|
72
IRIDEX
IRIX
$15.4M
| $406K | 0.39% |
53,250
-35,350
| -40% | -$302K |
|
73
C.H. Robinson
CHRW
$20.1B
| $405K | 0.39% |
+4,550
| New | +$371K |
|
74
Micron Technology
MU
$927B
| $397K | 0.38% |
9,650
-350
| -4% | -$15.1K |
|
75
LifeVantage
LFVN
$80.5M
| $387K | 0.37% |
81,225
| – | – |
|
Similar funds
SVP
PWP
BF
SFG
HWMG
CAG
FTEA
WT
Perkins Capital Management's Q4 2017 Portfolio in Review
As of Q4 2017, Perkins Capital Management held 124 positions worth $104M, up 9% from $95.4M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Perkins Capital Management deployed $7.51M of net new capital in Q4 2017, opening 22 new positions and adding to 30 existing holdings. Its largest new stake was Flexion Therapeutics, Inc.: 53,500 shares worth $1.34M.
By sector, the portfolio is most concentrated in Healthcare at 59% of assets, down from 64% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Axogen, an estimated $1.07M trimmed.
- Perkins Capital Management's largest Q4 2017 buy was Flexion Therapeutics, Inc.: 53,500 shares worth $1.34M.
- Perkins Capital Management added most to TearLab Corporation in Q4 2017, an estimated $1.85M increase.
- Perkins Capital Management's biggest Q4 2017 reduction was Axogen, cutting an estimated $1.07M.
- Perkins Capital Management fully exited Entellus Medical, Inc. Common Stock in Q4 2017, selling an estimated $1.05M.
- Perkins Capital Management's ten largest holdings make up 36% of its $104M portfolio in Q4 2017.
- Perkins Capital Management opened 22 new positions and closed 12 in Q4 2017.
- Perkins Capital Management's portfolio value rose 9% quarter-over-quarter to $104M.
Based on Perkins Capital Management's 13F filing for Q4 2017, filed 26 Jan 2018.